Moreover, the 5-year Decision Curve Analysis (DCA) showed that PDE2A, combined with tumor status, pathological stage, M stage, and T stage could predict well the prognosis and survival of HCC patients (Figure 5G). The gene discussed is PDE2A; the disease is hepatocellular carcinoma.